PERSPECTIVE THERAPEUTICS INC (CATX) Stock Analyst Ratings
USA - NYSEARCA:CATX - US46489V3024 - Common Stock
2.005 USD
-0.12 (-5.42%)
ChartMill assigns a Buy % Consensus number of 82% to CATX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 13.48. This target is 572.25% above the current price.
CATX was analyzed by 20 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about CATX.
In the previous month the buy percentage consensus was at a similar level.
CATX was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-13 | BTIG | Reiterate | Buy -> Buy |
| 2025-10-10 | BTIG | Initiate | Buy |
| 2025-10-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-23 | B. Riley Securities | Maintains | Buy -> Buy |
| 2025-06-23 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-06-03 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-05-14 | Truist Securities | Maintains | Buy -> Buy |
| 2025-04-07 | Truist Securities | Maintains | Buy -> Buy |
| 2025-03-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-27 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-03-27 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-03-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-13 | HC Wainwright & Co. | Initiate | Buy |
| 2025-03-07 | ScotiaBank | Initiate | Sector Outperform |
| 2025-01-14 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-11-25 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-11-25 | B of A Securities | Downgrade | Buy -> Neutral |
| 2024-11-22 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-10-24 | UBS | Initiate | Buy |
| 2024-10-24 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-10-11 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-10-01 | Wedbush | Initiate | Outperform |
| 2024-09-25 | Truist Securities | Initiate | Buy |
| 2024-09-10 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-09-09 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-09-06 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-09-03 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-08-16 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-08-13 | Oppenheimer | Maintains | Outperform -> Outperform |
PERSPECTIVE THERAPEUTICS INC / CATX FAQ
What do analysts expect the price target to be for PERSPECTIVE THERAPEUTICS INC (CATX)?
20 analysts have analysed CATX and the average price target is 13.48 USD. This implies a price increase of 572.25% is expected in the next year compared to the current price of 2.005.
What is the consensus rating for CATX stock?
The consensus rating for PERSPECTIVE THERAPEUTICS INC (CATX) is 82 / 100 . This indicates that analysts generally have a positive outlook on the stock.